What factors should influence the dosage and interval of prophylactic treatment in patients with severe haemophilia A and B?
Petrini P. Petrini P.
.
. Mt Sinai J Med. 2002 May;69(3):148-55. Mt Sinai J Med. 2002. PMID: 12035074 Review.
.
Item in Clipboard